SCHEMBL4642210

SCHEMBL4642210

CC(O)C(n1cncn1)n1cncn1

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 9/20 0.41
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
HSP90AA1 P07900 3/20 0.36
POLB P06746 1/20 0.36
TDP1 Q9NUW8 2/20 0.35
CYP3A4 P08684 2/20 0.34
CYP11B1 P15538 1/20 0.34
TSHR P16473 1/20 0.34
CYP11B2 P19099 1/20 0.34
CYP2C19 P33261 1/20 0.34
MAPT P10636 1/20 0.34
CYP26A1 O43174 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6630589 0.81
SCHEMBL27526816 0.78 CYP19A1 (0.39) CYP19A1KMT2AMEN1HSP90AA1POLB
SCHEMBL25619140 0.75 CYP19A1 (0.45) CYP19A1KMT2AMEN1HSP90AA1POLB
SCHEMBL11122463 0.75 HSP90AA1 (0.42) CYP19A1KMT2AMEN1HSP90AA1POLB
SCHEMBL29142623 0.74 CYP19A1 (0.36) CYP19A1KMT2AMEN1HSP90AA1POLB
SCHEMBL11389088 0.72 KMT2A (0.50) CYP19A1KMT2AMEN1HSP90AA1POLB
SCHEMBL22059457 0.71
SCHEMBL21165789 0.71 CYP19A1 (0.42) CYP19A1KMT2AMEN1HSP90AA1POLB
SCHEMBL9963220 0.71 CYP19A1 (0.42) CYP19A1KMT2AMEN1HSP90AA1POLB
SCHEMBL29973276 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108771019-A A kind of feed addictive for piglet opening food calling and promotion enteron aisle and skeleton development 宁波科瑞特动物药业有限公司 2018-11-09 CN claimed
EP-1804805-A4 USE OF AROMATASE INHIBITORS FOR THE TREATMENT OF ECTOPIC PREGNANCY UNIV WAYNE STATE (US) 2008-08-13 EP disclosed
EP-1804819-A4 USE OF AROMATASE INHIBITORS FOR ENDOMETRIAL THINNING IN PREPARATION FOR SURGICAL PROCEDURES ON THE ENDOMETRIAL CAVITY AND UTERUS UNIV WAYNE STATE (US) 2007-12-12 EP disclosed
EP-1804805-A2 USE OF AROMATASE INHIBITORS FOR THE TREATMENT OF ECTOPIC PREGNANCY WAYNE STATE UNIVERSITY (US) 2007-07-11 EP disclosed
EP-1804819-A2 USE OF AROMATASE INHIBITORS FOR ENDOMETRIAL THINNING IN PREPARATION FOR SURGICAL PROCEDURES ON THE ENDOMETRIAL CAVITY AND UTERUS WAYNE STATE UNIVERSITY (US) 2007-07-11 EP disclosed
WO-2006041939-A2 USE OF AROMATASE INHIBITORS FOR ENDOMETRIAL THINNING IN PREPARATION FOR SURGICAL PROCEDURES ON THE ENDOMETRIAL CAVITY AND UTERUS WAYNE STATE UNIVERSITY (US) 2006-04-20 WO disclosed
WO-2006041941-A2 USE OF AROMATASE INHIBITORS FOR THE TREATMENT OF ECTOPIC PREGNANCY WAYNE STATE UNIVERSITY (US) 2006-04-20 WO disclosed
EP-1492515-A1 PHARMACEUTICAL COMPOSITION COMPRISING AN AROMATASE INHIBITOR AND AN ESTROGEN SUITABLE FOR HORMONE REPLACEMENT THERAPY FOR A MALE JENCAP RESEARCH LTD. (CA) 2005-01-05 EP disclosed
WO-2003082254-A1 PHARMACEUTICAL COMPOSITION COMPRISING AN AROMATASE INHIBITOR AND AN ESTROGEN SUITABLE FOR HORMONE REPLACEMENT THERAPY FOR A MALE JENCAP RESEARCH LTD. (CA) 2003-10-09 WO disclosed
WO-2003082299-A1 IMPROVED HORMONE REPLACEMENT THERAPY JENCAP RESEARCH LTD. (CA) 2003-10-09 WO disclosed